Objective To establish a system conducive to generic drug companies based on the facts that although China has promised to implement the data monopoly system and patent term extension system for pharmaceutical compani...Objective To establish a system conducive to generic drug companies based on the facts that although China has promised to implement the data monopoly system and patent term extension system for pharmaceutical companies that hold the patents, yet China is a country that manufactures a large number of generic drugs each year which are closely related to citizens’ healthcare. Methods The US drug patent linkage system was studied through literature review methods and then the protection of the interests of generic drug companies in the drug-patent linkage system was explored based on the Cournot model. Results and Conclusion The policy of improving the quality of generic drugs and increasing the spillover effect of technology is more beneficial to generic drug companies. Based on the results, some policy suggestions are put forward, such as the implementation of the simplified application system for generic drugs and the consistency evaluation of generic drugs.展开更多
Objective To explore the extent to which the drug-patent linkage system should be implemented in China. Methods The present situation of drug-patent linkage system internationally was analyzed. Then the practices of d...Objective To explore the extent to which the drug-patent linkage system should be implemented in China. Methods The present situation of drug-patent linkage system internationally was analyzed. Then the practices of drug-patent linkage system were discussed through such methods as literature reviews and quantitative scoring methods in combination of selecting the representative countries. Finally the extent to which the drugpatent linkage system should be implemented in China was explored through comparative analysis. Results and Conclusion Compared with the United States, China should establish a drug-patent linkage system that will weaken the protection of original patented drugs and promote the timely marketing of high-quality generic drugs and appropriately prevent the patent abuse.展开更多
文摘Objective To establish a system conducive to generic drug companies based on the facts that although China has promised to implement the data monopoly system and patent term extension system for pharmaceutical companies that hold the patents, yet China is a country that manufactures a large number of generic drugs each year which are closely related to citizens’ healthcare. Methods The US drug patent linkage system was studied through literature review methods and then the protection of the interests of generic drug companies in the drug-patent linkage system was explored based on the Cournot model. Results and Conclusion The policy of improving the quality of generic drugs and increasing the spillover effect of technology is more beneficial to generic drug companies. Based on the results, some policy suggestions are put forward, such as the implementation of the simplified application system for generic drugs and the consistency evaluation of generic drugs.
文摘Objective To explore the extent to which the drug-patent linkage system should be implemented in China. Methods The present situation of drug-patent linkage system internationally was analyzed. Then the practices of drug-patent linkage system were discussed through such methods as literature reviews and quantitative scoring methods in combination of selecting the representative countries. Finally the extent to which the drugpatent linkage system should be implemented in China was explored through comparative analysis. Results and Conclusion Compared with the United States, China should establish a drug-patent linkage system that will weaken the protection of original patented drugs and promote the timely marketing of high-quality generic drugs and appropriately prevent the patent abuse.
